Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis

Gastroenterology
Richard MoreauNORFLOCIR Trial Investigators

Abstract

There is debate over the effects of long-term oral fluoroquinolone therapy in patients with advanced cirrhosis. We performed a randomized controlled trial to evaluate the effects of long-term treatment with the fluoroquinolone norfloxacin on survival of patients with cirrhosis. We performed a double-blind trial of 291 patients with Child-Pugh class C cirrhosis who had not received recent fluoroquinolone therapy. The study was performed at 18 clinical sites in France from April 2010 through November 2014. Patients were randomly assigned to groups given 400 mg norfloxacin (n = 144) or placebo (n = 147) once daily for 6 months. Patients were evaluated monthly for the first 6 months and at 9 months and 12 months thereafter. The primary outcome was 6-month mortality, estimated by the Kaplan-Meier method, censoring spontaneous bacterial peritonitis, liver transplantation, or loss during follow-up. The Kaplan-Meier estimate for 6-month mortality was 14.8% for patients receiving norfloxacin and 19.7% for patients receiving placebo (P = .21). In competing risk analysis that took liver transplantation into account, the cumulative incidence of death at 6 months was significantly lower in the norfloxacin group than in the placebo group (su...Continue Reading

Citations

Dec 18, 2018·European Journal of Gastroenterology & Hepatology·Sebastián MarcianoAdrián C Gadano
Jul 16, 2019·Expert Review of Gastroenterology & Hepatology·Antonio FacciorussoRodolfo Sacco
Jun 23, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcus M MückeChristian M Lange
Dec 5, 2019·Hepatology International·Vishal C Patel, Roger Williams
Jun 20, 2019·Canadian Journal of Gastroenterology & Hepatology·Jerônimo De Conto OliveiraMario R Alvares-da-Silva
Oct 22, 2019·Clinical Liver Disease·Guadalupe Garcia-Tsao
Oct 23, 2018·Visceral Medicine·Jonel TrebickaWim Laleman
Sep 22, 2020·Clinical and Translational Gastroenterology·Marcus M MückeEva Herrmann
Oct 23, 2018·Visceral Medicine·Christian M LangeJonel Trebicka
Jun 19, 2019·United European Gastroenterology Journal·Benedikt SimbrunnerThomas Reiberger
Aug 14, 2019·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Rosa Martin Mateos, Agustín Albillos
Feb 23, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Marika RudlerDominique Thabut
Oct 23, 2018·Visceral Medicine·Christian M Lange, Richard Moreau
Oct 18, 2020·Gut·Guruprasad P AithalSumita Verma
Nov 11, 2020·Applied Microbiology and Biotechnology·Heesu Kim, Dong Gun Lee
Dec 2, 2020·Nature Reviews. Gastroenterology & Hepatology·Jonel TrebickaManimozhiyan Arumugam
Feb 6, 2021·Hepatology International·Sonia SeliceanJordi Gracia-Sancho
Nov 19, 2020·JHEP Reports : Innovation in Hepatology·Giacomo ZaccheriniRichard Moreau
Jan 1, 2021·International Journal of Molecular Sciences·Na Young Lee, Ki Tae Suk
Dec 5, 2020·Journal of Hepatology·Giacomo ZaccheriniVicente Arroyo
Jan 20, 2019·Journal of Hepatology·Thierry Gustot, Rajiv Jalan
Apr 12, 2021·Clinics in Liver Disease·Salvatore Piano, Paolo Angeli
Apr 22, 2021·Expert Opinion on Pharmacotherapy·Daniel PörnerPhilipp Lutz
May 30, 2021·United European Gastroenterology Journal·Lorenz BalcarBernhard Scheiner
May 28, 2021·Journal of Hepatology·Javier FernándezEmmanuel Q Wey
Jun 17, 2021·The New England Journal of Medicine·Jasmohan S BajajK Rajender Reddy
Jun 23, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·François DurandClaire Francoz
Jan 29, 2021·Clinical and Molecular Hepatology·Salvatore PianoPaolo Angeli
Mar 8, 2020·Journal of Hepatology·Laura WeichselbaumStanislas Goriely
Sep 24, 2021·Alimentary Pharmacology & Therapeutics·Benedikt SimbrunnerThomas Reiberger
Jan 1, 2022·Expert Opinion on Drug Discovery·Sven LamatschCornelius Engelmann
Jan 19, 2022·The American Journal of Gastroenterology·Anand V KulkarniD Nageshwar Reddy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.